Last reviewed · How we verify

NCT07340203

Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation

Active, enrolled Last updated 14 January 2026
What this trial tests

trial testing survey in Constipation - Functional in 202 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 July 2025
Primary endpoint
12 December 2025
25 May 2026

Quick facts

Lead sponsorAhi Evran University Education and Research Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment202
Start date1 July 2025
Primary completion12 December 2025
Estimated completion25 May 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ahi Evran University Education and Research Hospital

Who can join

Adults 18 to 90, any sex, with Constipation - Functional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will conduct a validity and reliability study of the Wexner Constipation Questionnaire, used for constipation, in Turkish. For this purpose, investigators will administer the Wexner Questionnaire, translated from English to Turkish, and the accompanying Constipation Quality of Life Scale to 200 participants. Investigators will repeat the Wexner questionnaire for some participants after two weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of survey

Trials testing the same drug.

Other recruiting trials for Constipation - Functional

Currently open trials in the same condition.

Other Ahi Evran University Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07340203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing